DR10627, a Novel Dual Glucagon-like Peptide-1 and Gastric Inhibitory Polypeptide Receptor Agonist for the Treatment of Obesity and Type 2 Diabetes Mellitus
In: Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy, Jg. 17 (2024-04-30), S. 1563-1573
Online
academicJournal
Zugriff:
Titel: |
DR10627, a Novel Dual Glucagon-like Peptide-1 and Gastric Inhibitory Polypeptide Receptor Agonist for the Treatment of Obesity and Type 2 Diabetes Mellitus
|
---|---|
Autor/in / Beteiligte Person: | Shao, Yujian ; Chen, Yonglu ; Zhu, Mingyue ; Liu, Yuanyuan ; Fang, Chen ; Wang, Minjun ; Sun, Peng ; Fu, Weiling ; Huang, Jing ; Sheng, Shimei ; Huang, Yanshan |
Link: | |
Zeitschrift: | Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy, Jg. 17 (2024-04-30), S. 1563-1573 |
Veröffentlichung: | 2024 |
Medientyp: | academicJournal |
ISSN: | 1178-7007 (print) |
DOI: | 10.2147/DMSO.S457830 |
Sonstiges: |
|